BiotechTube
Nipro Medical

Nipro Medical

Clearwater, United States· Est.
nipro-group.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Nipro Medical Corporation, founded in 1984 and headquartered in Clearwater, Florida, is a commercial-stage medical device company operating in the renal care and vascular intervention markets. It is a key regional arm of the Japanese Nipro Group, leveraging global R&D to serve the North American market with products like the SURDIAL™ DX hemodialysis system and the Makoto™ intravascular imaging platform. The company is revenue-generating, supported by a broad portfolio of commercial products and a recent manufacturing expansion in Greenville, NC, indicating a commitment to growth and operational scale in the region.

Renal DiseaseCardiovascular DiseaseVascular Access

Technology Platform

Integrated platforms for renal care (hemodialysis systems, dialyzers, safety needles) and advanced vascular imaging (dual-modality IVUS+NIRS system for coronary plaque characterization).

Funding History

1
UndisclosedUndisclosed

Opportunities

The growing prevalence of chronic kidney disease and diabetes drives steady demand for dialysis products and services.
The shift towards intravascular imaging-guided PCI procedures creates a premium market for advanced systems like Makoto.
Local manufacturing expansion in North Carolina can improve supply chain reliability and cater to regional preferences.

Risk Factors

Faces intense competition from larger, well-capitalized global medtech companies in both renal and vascular markets.
Revenue is heavily influenced by U.S.
healthcare reimbursement policies, particularly Medicare rates for dialysis.
Integration and strategic execution risks as a subsidiary of a Japan-based parent company.

Competitive Landscape

In renal care, competes directly with giants like Fresenius Medical Care, Baxter, and B. Braun. In intravascular imaging, competes with Philips (IVUS), Boston Scientific, and Abbott (OCT). Differentiation is achieved through specialized dialyzer membranes, safety-focused needle designs, and the unique dual IVUS+NIRS capability of the Makoto system.

More companies in Drug Delivery & Formulation →More companies in United States →